Cysladek Oral Drops 15 mL carton

Cysladek® Oral Drops

Fat-Soluble Vitamin ADEK Supplementation

Cysladek® Oral Drops is an oral liquid formulation containing four essential fat-soluble vitamins, Vitamin A, Vitamin D, Vitamin E and Vitamin K1 provided in an MCT-based lipid vehicle. It is formulated to provide fat-soluble vitamin supplementation in patients in whom nutritional requirements may be increased or absorption may be compromised, based on the underlying clinical condition and healthcare professional assessment.

Cysladek® Oral Drops Composition

Each drop contains:

  • Vitamin A: 350 IU
  • Vitamin D: 400 IU
  • Vitamin E: 5 mg
  • Vitamin K1: 2.5 mcg
  • The formulation uses medium-chain triglycerides (MCTs) as the lipid vehicle for delivery of the fat-soluble vitamins.

Medium-chain triglycerides (MCTs) Based Formulation

Medium-chain triglycerides (MCTs) are triglycerides containing predominantly medium-chain fatty acids a lipid-based vehicle for delivery of fat-soluble vitamins. Their physicochemical and digestive characteristics differ from those of long-chain triglycerides (LCTs).

Unlike many dietary long-chain fats, medium-chain fatty acids undergo relatively rapid digestion and absorption and are transported predominantly through the portal circulation. These characteristics have supported the use of MCTs-containing nutritional formulations in selected clinical settings where conventional fat digestion or absorption may be impaired.

Benefits of Medium chain Triglycerides (MCTs)-Based Formulation

Fat-soluble vitamins require an appropriate lipid environment for formulation and intestinal absorption. MCTs-based vehicle provides a lipid carrier system for incorporating and delivering Vitamins A, D, E and K in an oral liquid dosage form.

  • Improve Solubility: MCTs act as an efficient lipid carrier, helping dissolve and deliver fat-soluble Vitamins A, D, E & K.
  • Enhance Absorption: MCTs are directly absorbed into the portal circulation and transported bound to albumin, no bile and pancreatic enzymes required.
  • Improve Bioavailability: MCTs create a lipophilic environment that enhances the stability and availability of fat-soluble vitamins for absorption.
  • Better Stability: MCTs are less prone to oxidation, contributing to improved formulation stability and sustained vitamin potency.

What makes Cysladek® different from regular multivitamins?

Four fat-soluble vitamins in a single oral dosage form Cysladek® Oral Drops provides Vitamins A, D, E and K1 together in an MCT-based oral liquid formulation.

How long should treatment continue?

Depends on condition:

  • Cholestasis → till bile flow improves
  • Chronic diseases → may require long-term supplementation

How quickly can results be seen?

  • Improvement in vitamin levels occurs gradually; clinical benefits depend on severity and compliance.

Cysladek® Oral drops any side effects.

  • Generally well tolerated.
  • However, excessive intake of fat-soluble vitamins (especially A & D) may lead to toxicity monitoring is advised.

Product Specifications

  • Dosage form: Drops
  • Pack size: 15 mL
  • Storage Conditions: Store below 30°C, Protect from direct sunlight.
  • Each bottle contains Vitamin ADEK Premix 06.00 gm, Medium chain triglyceride 09.00 gm
  • Quantitative Composition:
  • Each drop contains
  • Vitamin A: 350 IU
  • Vitamin D: 400 IU
  • Vitamin E: 5 mg
  • Vitamin K1: 2.5 mcg

Administration

Dosage titrated to individual patient response based on clinical assessment.

Use the supplied dosing dropper where applicable to ensure accurate administration.

Follow the approved product instructions for administration and storage.

Storage

  • Store below 30°C in a cool, dry place.
  • Protect the bottle from direct sunlight and excessive heat.
  • Do not freeze.
  • Keep the bottle tightly closed when not in use.
  • Keep out of reach of children.

Commercial Information

  • Available Pack Sizes: 15 ml bottle
  • Pricing Information: ₹513 (Maximum Retail Price)
  • Where to Purchase: Can be sourced by directly calling the customer care fulfilment line at 7337585050

Disclaimer

Cysladek® Oral Drops is intended solely for fat-soluble vitamin supplementation. This product is not intended to treat, cure, or replace the clinical management of any underlying disease or cause of malabsorption. Healthcare professionals must continue to provide appropriate, disease-specific management and nutritional care as clinically indicated.

References:

  • Zuvarox T, Goosenberg E, Belletieri C. Malabsorption Syndromes. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. [updated 2025 Jul 7; cited 2026 Sep 16]. Available from: nih.gov
  • Pucinischi V, Giarrusso G, Gallo G, Di Nardo G, Furio S, Mennini M, et al. Enhancing pediatric practice: a comprehensive review on malabsorption in pediatrics for diagnostic and management approach. Nutrition. 2025;140:112895. doi: 10.1016/j.nut.2025.112895.
  • Zuvarox T, Goosenberg E, Belletieri C. Malabsorption Syndromes. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. [Updated 2025 Jul . Available from: https://www.ncbi.nlm.nih.gov/books/NBK553106/
  • Cleveland Clinic. Malabsorption (Syndrome): Symptoms, Causes & Treatment. Reviewed April 6, 2022. Accessed September 16, 2026. https://my.clevelandclinic.org/health/diseases/22722-malabsorption
  • Pal R, Mukhopadhyay S. Indian Academy of Pediatrics guidelines on cholestasis. Indian Pediatr. 2014 Mar;51(3):203-10. doi: 10.1007/s13312-014-0375-2.
  • Heidt C. Medium-chain triglycerides: scientific and regulatory perspectives from Germany and Japan with a US context—a concise review. Nutrients. 2026 Mar 24;18(7):1027. doi: 10.3390/nu18071027.
  • Andrès E. Fat-soluble vitamins A, D, E, and K: review of the literature and points of interest for the clinician. J Clin Med [Internet]. 2024 Jun 21 [cited 2026 Sep 22];13(13):3641. Available from: doi.org.
  • Reddy P, Jialal I. Biochemistry, fat soluble vitamins [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Sep 19 [cited 2026 Sep 22]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534869/
  • Jadhav HB, Annapure US. Triglycerides of medium‑chain fatty acids: a concise review. J Food Sci Technol. 2023 Aug;60(8):2143–2152. doi: 10.1007/s13197-022-05499-w.